Development of a Clinical Disease Activity Measure for Juvenile Localized Scleroderma.

被引：0
|
作者：
Li, Suzanne C. [1 ]
Torok, Kathryn S. [2 ]
Pope, Elena [3 ]
Stewart, Katie G. [4 ]
Higgins, Gloria C. [5 ]
Rabinovich, Egla C. [6 ]
O'Neil, Kathleen M. [7 ]
Foeldvari, Ivan [8 ]
Haines, Kathleen A. [1 ]
Jacobe, Heidi [9 ]
Punaro, Marilynn G. [4 ]
Laxer, Ronald M. [3 ]
Nyirenda, Themba [1 ]
Wittkowski, Knut M. [10 ]
机构：
[1] Hackensack Univ Med Ctr, Hackensack, NJ USA
[2] Univ Pittsburgh Med Ctr, Pittsburgh, PA USA
[3] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[4] Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA
[5] Nationwide Childrens Hosp, Columbus, OH USA
[6] Duke Univ Med Ctr, Durham, NC USA
[7] Okla Univ Hlth Sci Ctr, Oklahoma City, OK USA
[8] Hamburger Zentrum Kinder & Jugendrheumatol, Hamburg, Germany
[9] UT SW Med Ctr Dallas, Dallas, TX USA
[10] Rockefeller Univ, New York, NY 10021 USA
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2453
引用
收藏
页码：S955 / S956
页数：2
相关论文
共 50 条
  • [31] Development of new Consensus Treatment Plans for the juvenile localized Scleroderma
    不详
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2014, 73 (05): : 399 - 399
  • [32] Juvenile Localized Scleroderma of the face: a neuro-cutaneous disease?
    Parolin, Mattia
    Vittadello, Fabio
    Calderone, Milena
    Ullman, Susanne
    Martini, Giorgia
    Zulian, Francesco
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 390 - 390
  • [33] Reliability and Validity of a New Skin Activity Measure for Localized Scleroderma
    Li, Suzanne
    Becker, Mara
    Hong, Sandy
    Ferguson, Polly
    Nyrienda, Themba
    Andrews, Tracy
    Stewart, Katie
    Rabinovich, C. Egla
    Fuhlbrigge, Robert
    Mason, Thomas
    Pope, Elena
    Ibarra, Maria
    Dedeoglu, Fatma
    Higgins, Gloria
    Laxer, Ronald
    Punaro, Marilynn
    Torok, Kathryn
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [34] Reliability and Validity of a New Skin Activity Measure for Localized Scleroderma
    Li, Suzanne
    Becker, Mara
    Hong, Sandy
    Ferguson, Polly
    Nyrienda, Themba
    Andrews, Tracy
    Stewart, Katie
    Rabinovich, C. Egla
    Fuhlbrigge, Robert
    Mason, Thomas
    Pope, Elena
    Ibarra, Maria
    Dedeoglu, Fatma
    Higgins, Gloria
    Laxer, Ronald
    Punaro, Marilynn
    Torok, Kathryn
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 : 137 - 139
  • [35] Extracutaneous involvement is common and associated with prolonged disease activity and greater impact in juvenile localized scleroderma
    Li, Suzanne C.
    Higgins, Gloria C.
    Chen, Mallory
    Torok, Kathryn S.
    Rabinovich, C. Egla
    Stewart, Katie
    Laxer, Ronald M.
    Pope, Elena
    Haines, Kathleen A.
    Punaro, Marilynn
    O'Neil, Kathleen M.
    RHEUMATOLOGY, 2021, 60 (12) : 5724 - 5733
  • [36] Clinical trials for the treatment of systemic sclerosis/scleroderma.
    Varga J.
    Ponor I.
    Current Rheumatology Reports, 1999, 1 (1) : 13 - 14
  • [37] Abatacept Treatment Reduces Cutaneous and Joint Activity in Juvenile Localized Scleroderma
    Li, Suzanne
    Ishaq, Sarah
    Buckley, Mary
    Torok, Kathryn
    Edelheit, Barbara
    Ede, Kaleo
    Liu, Christopher
    Rabinovich, C. Egla
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [38] Hand risk factors for the development of disability in scleroderma.
    Poole, JL
    Watzlaf, VJM
    DAmico, F
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1709 - 1709
  • [39] Anti-DNA topoisomerase II alpha autoantibodies in localized scleroderma.
    Hayakawa, I
    Sato, S
    Takehara, K
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S352 - S352
  • [40] Transcriptomic Evaluation of Juvenile Localized Scleroderma Skin With Histologic and Clinical Correlation
    Schutt, Christina
    Mirizio, Emily
    Salgado, Claudia
    Reyes-Mugica, Miguel
    Wang, Xinjun
    Chen, Wei
    Grunwaldt, Lorelei
    Schollaert, Kaila L.
    Torok, Kathryn S.
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (10) : 1921 - 1930
12345